Literature DB >> 20059482

Sequential expression of macrophage anti-microbial/inflammatory and wound healing markers following innate, alternative and classical activation.

F M Menzies1, F L Henriquez, J Alexander, C W Roberts.   

Abstract

The present study examines the temporal dynamics of macrophage activation marker expression in response to variations in stimulation. We demonstrate that markers can be categorized as 'early' (expressed most abundantly at 6 h post-stimulation) or 'late' (expressed at 24 h post-stimulation). Thus nos2 and p40 (IL-12/IL-23) are early markers of innate and classical activation, while dectin-1 and mrc-1 are early markers and fizz1 (found in inflammatory zone-1) and ym1 are late markers of alternative activation. Furthermore, argI is a late marker of both innate and alternative activation. The ability of interferon (IFN)-gamma to alter these activation markers was studied at both the protein level and gene level. As reported previously, IFN-gamma was able to drive macrophages towards the classical phenotype by enhancing nos2 gene expression and enzyme activity and p40 (IL-12/IL-23) gene expression in lipopolysaccharide (LPS)-stimulated macrophages. IFN-gamma antagonized alternative macrophage activation, as evident by reduced expression of dectin-1, mrc-1, fizz1 and ym1 mRNA transcripts. In addition, IFN-gamma antagonized arginase activity irrespective of whether macrophages were activated innately or alternatively. Our data explain some apparent contradictions in the literature, demonstrate temporal plasticity in macrophage activation states and define for the first time 'early' and 'late' markers associated with anti-microbial/inflammatory and wound healing responses, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20059482      PMCID: PMC2883107          DOI: 10.1111/j.1365-2249.2009.04086.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  55 in total

1.  Immune recognition. A new receptor for beta-glucans.

Authors:  G D Brown; S Gordon
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

2.  Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro.

Authors:  Meera G Nair; Daniel W Cochrane; Judith E Allen
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

Review 3.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

Review 4.  The many faces of macrophage activation.

Authors:  David M Mosser
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

5.  Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages.

Authors:  Geert Raes; Patrick De Baetselier; Wim Noël; Alain Beschin; Frank Brombacher; Gholamreza Hassanzadeh Gh
Journal:  J Leukoc Biol       Date:  2002-04       Impact factor: 4.962

6.  Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide.

Authors:  Janet A Willment; Hsi-Hsien Lin; Delyth M Reid; Philip R Taylor; David L Williams; Simon Y C Wong; Siamon Gordon; Gordon D Brown
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

7.  The macrophage mannose receptor induces IL-17 in response to Candida albicans.

Authors:  Frank L van de Veerdonk; Renoud J Marijnissen; Bart Jan Kullberg; Hans J P M Koenen; Shih-Chin Cheng; Irma Joosten; Wim B van den Berg; David L Williams; Jos W M van der Meer; Leo A B Joosten; Mihai G Netea
Journal:  Cell Host Microbe       Date:  2009-04-23       Impact factor: 21.023

8.  Upregulation of arginase expression in wound-derived fibroblasts.

Authors:  Maria B Witte; Adrian Barbul; Martin A Schick; Nicole Vogt; Horst Dieter Becker
Journal:  J Surg Res       Date:  2002-06-01       Impact factor: 2.192

9.  FIZZ1 and Ym as tools to discriminate between differentially activated macrophages.

Authors:  Geert Raes; Wim Noël; Alain Beschin; Lea Brys; Patrick de Baetselier; G H G Hassanzadeh
Journal:  Dev Immunol       Date:  2002-09

Review 10.  Novel IL-12 family members shed light on the orchestration of Th1 responses.

Authors:  Frank Brombacher; Robert A Kastelein; Gottfried Alber
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

View more
  45 in total

1.  Selective inhibition and augmentation of alternative macrophage activation by progesterone.

Authors:  Fiona M Menzies; Fiona L Henriquez; James Alexander; Craig W Roberts
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Estrogen receptor-alpha promotes alternative macrophage activation during cutaneous repair.

Authors:  Laura Campbell; Elaine Emmerson; Helen Williams; Charis R Saville; Andrée Krust; Pierre Chambon; Kimberly A Mace; Matthew J Hardman
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

Review 3.  Neuroinflammation and microglia in glaucoma: time for a paradigm shift.

Authors:  Xin Wei; Kin-Sang Cho; Eric F Thee; Martine J Jager; Dong Feng Chen
Journal:  J Neurosci Res       Date:  2018-05-18       Impact factor: 4.164

4.  Role of reactive nitrogen species generated via inducible nitric oxide synthase in vesicant-induced lung injury, inflammation and altered lung functioning.

Authors:  Vasanthi R Sunil; Jianliang Shen; Kinal Patel-Vayas; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-03-14       Impact factor: 4.219

5.  Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth.

Authors:  Olga D Chuquimia; Dagbjort H Petursdottir; Natalia Periolo; Carmen Fernández
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

Review 6.  Alternatively activated macrophages in spinal cord injury and remission: another mechanism for repair?

Authors:  Taekyun Shin; Meejung Ahn; Changjong Moon; Seungjoon Kim; Ki-Bum Sim
Journal:  Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.590

Review 7.  Macrophage phenotypes during tissue repair.

Authors:  Margaret L Novak; Timothy J Koh
Journal:  J Leukoc Biol       Date:  2013-03-15       Impact factor: 4.962

Review 8.  Key mechanisms involved in ionizing radiation-induced systemic effects. A current review.

Authors:  Ifigeneia V Mavragani; Danae A Laskaratou; Benjamin Frey; Serge M Candéias; Udo S Gaipl; Katalin Lumniczky; Alexandros G Georgakilas
Journal:  Toxicol Res (Camb)       Date:  2015-08-11       Impact factor: 3.524

9.  Schistosoma mansoni hemozoin modulates alternative activation of macrophages via specific suppression of Retnla expression and secretion.

Authors:  Martha Truscott; D Andrew Evans; Matt Gunn; Karl F Hoffmann
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

10.  IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws.

Authors:  Qunzhou Zhang; Ikiru Atsuta; Shiyu Liu; Chider Chen; Shihong Shi; Songtao Shi; Anh D Le
Journal:  Clin Cancer Res       Date:  2013-04-24       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.